Recombinant Human Mammary Serine Protease Inhibitor (rHuMaspin, P36952, 5268) CAS#: 402-01-1816; ChemWhat Code: 1404152

Official Full Name Recombinant Human Mammary Serine Protease Inhibitor (rHuMaspin)
Squence Squence of Recombinant Human Mammary Serine Protease Inhibitor
Amino Acid Sequence MDALQLANSA FAVDLFKQLC EKEPLGNVLF SPICLSTSLS LAQVGAKGDT ANEIGQVLHF ENVKDIPFGF QTVTSDVNKL SSFYSLKLIK RLYVDKSLNL STEFISSTKR PYAKELETVD FKDKLEETKG QINNSIKDLT DGHFENILAD NSVNDQTKIL VVNAAYFVGK WMKKFPESET KECPFRLNKT DTKPVQMMNM EATFCMGNID SINCKIIELP FQNKHLSMFI LLPKDVEDES TGLEKIEKQL NSESLSQWTN PSTMANAKVK LSIPKFKVEK MIDPKACLEN LGLKHIFSED TSDFSGMSET KGVALSNVIH KVCLEITEDG GDSIEVPGAR ILQHKDELNA DHPFIYIIRH NKTRNIIFFG KFCSP
Synonyms SerpinB5, Protease Inhibitor 5
Accession Number P36952
GeneID 5268
Summary
Source Escherichia coli.
Molecular Weight Approximately 42.1 kDa, a single non-glycosylated polypeptide chain containing 375 amino acid residues.
Biological Activity No data available
Appearance Sterile filtered white lyophilized (freeze-dried) powder.
Formulation Lyophilized from a 0.2 um filtered concentrated solution in PBS, pH 7.4.
Endotoxin Less than 1 EU/ug of rHuMaspin as determined by LAL method.
Reconstitution We recommend that this vial be briefly centrifuged prior to opening to bring the contents to the bottom. Reconstitute in sterile distilled water or aqueous buffer containing 0.1 % BSA to a concentration of 0.1-1.0 mg/mL. Stock solutions should be apportioned into working aliquots and stored at ≤ -20 °C. Further dilutions should be made in appropriate buffered solutions.
Stability and Storage Use a manual defrost freezer and avoid repeated freeze-thaw cycles.- 12 months from date of receipt, -20 to -70 °C as supplied.- 1 month, 2 to 8 °C under sterile conditions after reconstitution.- 3 months, -20 to -70 °C under sterile conditions after reconstitution.
References 1. Goulet B, Kennette W, Ablack A, et al. 2011. Lab Invest, 91: 1181-7.2. Schwarz S, Ettl T, Kleinsasser N, et al. 2008. Oral Oncol, 44: 563-70.3. Abd El-Wahed MM. 2005. J Egypt Natl Canc Inst, 17: 173-83.4. Katakura H, Takenaka K, Nakagawa M, et al. 2006. Lung Cancer, 51: 323-8.
SDS-PAGE SDS-PAGE of Recombinant Human Mammary Serine Protease Inhibitor
Safety Data Sheet (SDS) Download Click to download
Technical Data Sheet (TDS) Download Click to download

Buy Reagent

ChemWhat 14041525ug/100ug/500ug (> 95 % by SDS-PAGE and HPLC)
No reagent supplier? Send quick inquiry to ChemWhat
Want to be listed here as a reagent supplier? (Paid service) Click here to contact ChemWhat

Approved Manufacturers

Want to be listed as an approved manufacturer (Requires approvement)? Please download and fill out this form and send back to approved-manufacturers@chemwhat.com

Contact Us for Other Help

Contact us for other information or services Click here to contact ChemWhat